$PARS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PHARMOS CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PHARMOS CORP. Get notifications about new insider transactions in PHARMOS CORP for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 05 2012 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 20,000 | |
Jul 03 2012 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jul 03 2012 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jan 11 2012 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jan 10 2012 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jan 10 2012 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.06 | 20,000 | 1,200 | 20,000 | |
Jul 06 2011 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.13 | 25,000 | 3,250 | 25,000 | |
Jul 06 2011 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.13 | 25,000 | 3,250 | 25,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | President and CFO | Option Exercise | A | 0.09 | 400,000 | 36,000 | 400,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.09 | 50,000 | 4,500 | 50,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Option Exercise | A | 0.09 | 300,000 | 27,000 | 300,000 | |
Mar 30 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 3,628 | 327 | 11,946,271 | 11.9 M to 11.9 M (+0.03 %) |
Mar 22 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 81,708 | 7,354 | 11,933,644 | 11.9 M to 11.9 M (+0.69 %) |
Mar 25 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 8,999 | 810 | 11,942,643 | 11.9 M to 11.9 M (+0.08 %) |
Mar 22 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 57,015 | 5,131 | 11,851,936 | 11.8 M to 11.9 M (+0.48 %) |
Mar 10 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 42,910 | 3,862 | 11,794,921 | 11.8 M to 11.8 M (+0.37 %) |
Mar 07 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 4,590 | 390 | 11,752,011 | 11.7 M to 11.8 M (+0.04 %) |
Mar 03 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.09 | 52,500 | 4,699 | 11,747,421 | 11.7 M to 11.7 M (+0.45 %) |
Jan 07 2011 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.09 | 20,000 | 1,800 | 20,000 | |
Jan 07 2011 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.09 | 25,000 | 2,250 | 25,000 | |
Jan 06 2011 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.09 | 25,000 | 2,250 | 25,000 | |
Jan 03 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 20,000 | 1,998 | 11,694,567 | 11.7 M to 11.7 M (+0.17 %) |
Jan 03 2011 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 54,000 | 5,400 | 11,674,567 | 11.6 M to 11.7 M (+0.46 %) |
Dec 27 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 81,190 | 8,119 | 11,620,567 | 11.5 M to 11.6 M (+0.70 %) |
Dec 22 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 4,970 | 497 | 11,539,377 | 11.5 M to 11.5 M (+0.04 %) |
Dec 22 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 7,000 | 700 | 11,534,407 | 11.5 M to 11.5 M (+0.06 %) |
Dec 22 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 6,840 | 684 | 11,527,407 | 11.5 M to 11.5 M (+0.06 %) |
Sep 07 2010 | PARS | PHARMOS CORP | Leventer Steven | Director | Option Exercise | A | 0.12 | 350,000 | 42,000 | 350,000 | |
Aug 12 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.08 | 23,000 | 1,725 | 11,520,567 | 11.5 M to 11.5 M (+0.20 %) |
Aug 12 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.07 | 34,000 | 2,516 | 11,497,567 | 11.5 M to 11.5 M (+0.30 %) |
Jul 22 2010 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jul 21 2010 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.06 | 20,000 | 1,200 | 20,000 | |
Jul 21 2010 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.06 | 25,000 | 1,500 | 25,000 | |
Jun 04 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Sell | S | 0.06 | 244,382 | 14,590 | 11,463,567 | 11.7 M to 11.5 M (-2.09 %) |
Jun 04 2010 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Sell | S | 0.06 | 350,000 | 22,470 | 11,707,949 | 12.1 M to 11.7 M (-2.90 %) |
Mar 15 2010 | PARS | PHARMOS CORP | VENROCK ASSOCIATES | 10% Owner | Buy | J | 0.05 | 7,422 | 401 | 193,302 | 185.9 K to 193.3 K (+3.99 %) |
Mar 15 2010 | PARS | PHARMOS CORP | VENROCK ASSOCIATES | 10% Owner | Buy | J | 0.05 | 296,904 | 16,033 | 7,732,159 | 7.4 M to 7.7 M (+3.99 %) |
Mar 15 2010 | PARS | PHARMOS CORP | VENROCK ASSOCIATES | 10% Owner | Buy | J | 0.05 | 66,803 | 3,607 | 1,739,735 | 1.7 M to 1.7 M (+3.99 %) |
Jan 22 2010 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jan 22 2010 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.08 | 25,000 | 2,000 | 25,000 | |
Jan 21 2010 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.08 | 20,000 | 1,600 | 20,000 | |
Jul 06 2009 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.24 | 20,000 | 4,800 | 20,000 | |
Jul 06 2009 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.24 | 30,000 | 7,200 | 30,000 | |
Jul 06 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.24 | 25,000 | 6,000 | 25,000 | |
May 13 2009 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.22 | 100,000 | 22,000 | 100,000 | |
May 13 2009 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | President and CFO | Option Exercise | A | 0.22 | 600,000 | 132,000 | 600,000 | |
May 12 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Grant | A | 0.22 | 1,200,000 | 264,000 | 12,057,949 | 10.9 M to 12.1 M (+11.05 %) |
May 12 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | J | 0.05 | 99,660 | 5,382 | 10,857,949 | 10.8 M to 10.9 M (+0.93 %) |
May 12 2009 | PARS | PHARMOS CORP | NEW ENTERPRISE ASSOCIATES 10 L ... | 10% Owner | Buy | J | 0.05 | 543,427 | 29,345 | 14,435,105 | 13.9 M to 14.4 M (+3.91 %) |
May 12 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.05 | 543,427 | 29,345 | 14,435,105 | 13.9 M to 14.4 M (+3.91 %) |
Apr 23 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Option Exercise | P | 0.12 | 6,000,000 | 720,000 | 6,000,000 | |
Apr 23 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | C | 0.00 | 3,715,190 | 0 | 10,758,289 | 7 M to 10.8 M (+52.75 %) |
Apr 23 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Buy | P | 0.10 | 6,000,000 | 600,000 | 7,043,099 | 1 M to 7 M (+575.21 %) |
Apr 23 2009 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | P | 0.12 | 4,000,000 | 480,000 | 4,000,000 | |
Apr 23 2009 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | P | 0.00 | 7,715,190 | 0 | 9,294,067 | 1.6 M to 9.3 M (+488.65 %) |
Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.12 | 8,000,000 | 960,000 | 8,000,000 | |
Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.28 | 3,636,364 | 1,000,000 | 13,891,678 | 10.3 M to 13.9 M (+35.46 %) |
Apr 23 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.10 | 8,000,000 | 800,000 | 10,176,488 | 2.2 M to 10.2 M (+367.56 %) |
Jan 27 2009 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.14 | 20,000 | 2,800 | 20,000 | |
Jan 20 2009 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.14 | 22,500 | 3,150 | 22,500 | |
Jan 16 2009 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Grant | A | 0.34 | 147,059 | 50,000 | 1,043,099 | 896 K to 1 M (+16.41 %) |
Jan 16 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.14 | 22,500 | 3,150 | 22,500 | |
Jan 16 2009 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.34 | 147,059 | 50,000 | 2,176,488 | 2 M to 2.2 M (+7.25 %) |
Aug 07 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Grant | A | 0.36 | 148,605 | 53,201 | 1,438,067 | 1.3 M to 1.4 M (+11.52 %) |
Jul 18 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Grant | A | 0.36 | 148,605 | 53,201 | 2,029,429 | 1.9 M to 2 M (+7.90 %) |
Jul 03 2008 | PARS | PHARMOS CORP | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | A | 0.39 | 20,000 | 7,800 | 20,000 | |
Jul 03 2008 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.39 | 20,000 | 7,800 | 20,000 | |
Jul 03 2008 | PARS | PHARMOS CORP | MILLER LLOYD I III | Director | Option Exercise | A | 0.39 | 25,000 | 9,750 | 25,000 | |
Jul 02 2008 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 0.39 | 20,000 | 7,800 | 20,000 | |
Jul 02 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.39 | 22,500 | 8,775 | 22,500 | |
Jul 02 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.39 | 22,500 | 8,775 | 22,500 | |
Jan 25 2008 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | President and CFO | Option Exercise | A | 0.35 | 130,000 | 45,500 | 130,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | President and CFO | Grant | A | 0.35 | 75,000 | 26,250 | 75,000 | 0 to 75 K |
Jan 25 2008 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 0.35 | 20,000 | 7,000 | 20,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | Johnston Robert F | Executive Chairman | Option Exercise | A | 0.35 | 350,000 | 122,500 | 350,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 0.35 | 22,500 | 7,875 | 22,500 | |
Jan 25 2008 | PARS | PHARMOS CORP | MILLER LLOYD I III | 10% Owner | Option Exercise | A | 0.35 | 25,000 | 8,750 | 25,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | A | 0.35 | 20,000 | 7,000 | 20,000 | |
Jan 25 2008 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 0.35 | 22,500 | 7,875 | 22,500 | |
Jan 25 2008 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 0.35 | 20,000 | 7,000 | 10,000 | |
Jan 07 2008 | PARS | PHARMOS CORP | MILLER LLOYD I III | 10% Owner | Option Exercise | P | 0.70 | 1,000,000 | 700,000 | 1,000,000 | |
Jan 07 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | P | 0.70 | 20,000 | 14,000 | 20,000 | |
Jan 07 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | P | 0.70 | 800,000 | 560,000 | 800,000 | |
Jan 07 2008 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | P | 0.70 | 180,000 | 126,000 | 180,000 | |
Oct 26 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Chief Executive Off ... | Option Exercise | A | 1.46 | 200,000 | 292,000 | 200,000 | |
Apr 03 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Chief Executive Off ... | Option Exercise | A | 1.46 | 200,000 | 292,000 | 200,000 | |
Feb 28 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | CEO designate | Option Exercise | A | 1.55 | 150,000 | 232,500 | 150,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | SCHLACHET DAVID | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | Sartani Abraham | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | MILLER LLOYD I III | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | JP MORGAN PARTNERS BHCA LP | 10% Owner | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | NEWHALL CHARLES W III | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 19 2007 | PARS | PHARMOS CORP | AKKARAJU SRINIVAS | Director | Option Exercise | A | 1.84 | 20,000 | 36,800 | 20,000 | |
Jan 18 2007 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | Chief Financial Off ... | Option Exercise | A | 1.84 | 40,000 | 73,600 | 40,000 | |
Jan 18 2007 | PARS | PHARMOS CORP | Rubino Alan L | President and COO | Option Exercise | A | 1.84 | 50,000 | 92,000 | 50,000 | |
Jan 18 2007 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | A | 1.84 | 60,000 | 110,400 | 60,000 | |
Nov 13 2006 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | P | 1.90 | 5,000 | 9,496 | 202,423 | 197.4 K to 202.4 K (+2.53 %) |
Oct 10 2006 | PARS | PHARMOS CORP | NEILL SYDNEY COLIN | Chief Financial Off ... | Option Exercise | A | 1.75 | 90,000 | 157,500 | 90,000 | |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 25,665 | 0 | 25,665 | 0 to 25.7 K |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 1,026,569 | 0 | 1,026,569 | 0 to 1 M |
Oct 27 2006 | PARS | PHARMOS CORP | EVNIN ANTHONY B | Director | Buy | J | 0.00 | 230,978 | 0 | 230,978 | 0 to 231 K |
Sep 21 2006 | PARS | PHARMOS CORP | MILLER LLOYD I III | 10% Owner | Buy | P | 1.65 | 2,240 | 3,696 | 1,603,097 | 1.6 M to 1.6 M (+0.14 %) |
Sep 18 2006 | PARS | PHARMOS CORP | MILLER LLOYD I III | 10% Owner | Buy | P | 1.66 | 20,010 | 33,207 | 1,600,857 | 1.6 M to 1.6 M (+1.27 %) |
Jun 08 2006 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | P | 2.34 | 5,000 | 11,700 | 197,423 | 192.4 K to 197.4 K (+2.60 %) |
Jun 02 2006 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | P | 2.40 | 5,000 | 12,000 | 192,423 | 187.4 K to 192.4 K (+2.67 %) |
May 31 2006 | PARS | PHARMOS CORP | Rubino Alan L | President and COO | Buy | P | 2.11 | 1,000 | 2,110 | 1,000 | 0 to 1,000 |
May 25 2006 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | P | 2.12 | 5,000 | 10,597 | 187,423 | 182.4 K to 187.4 K (+2.74 %) |
Jan 27 2006 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | A | 2.15 | 325,000 | 698,750 | 325,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | SCHLACHET DAVID | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | Meer James | Senior VP and CFO | Option Exercise | A | 2.15 | 25,000 | 53,750 | 25,000 | |
Jan 27 2006 | PARS | PHARMOS CORP | Sartani Abraham | Director | Option Exercise | A | 2.15 | 20,000 | 43,000 | 20,000 | |
Nov 15 2005 | PARS | PHARMOS CORP | Rubino Alan L | President and COO | Option Exercise | A | 2.18 | 325,000 | 708,500 | 325,000 | |
Jun 30 2005 | PARS | PHARMOS CORP | Sartani Abraham | Director | Option Exercise | A | 2.41 | 10,000 | 24,100 | 10,000 | |
Jun 22 2005 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | P | 2.54 | 2,000 | 5,080 | 2,000 | 0 to 2 K |
Jun 17 2005 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Buy | P | 2.57 | 1,000 | 2,570 | 1,000 | 0 to 1,000 |
Jun 13 2005 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Buy | P | 2.49 | 15,000 | 37,275 | 852,111 | 837.1 K to 852.1 K (+1.79 %) |
Jun 06 2005 | PARS | PHARMOS CORP | Meer James | Sr. Vice President ... | Buy | P | 2.44 | 1,200 | 2,928 | 12,000 | 10.8 K to 12 K (+11.11 %) |
Jun 06 2005 | PARS | PHARMOS CORP | Meer James | Sr. Vice President ... | Buy | P | 2.49 | 10,800 | 26,892 | 10,800 | 0 to 10.8 K |
Feb 22 2005 | PARS | PHARMOS CORP | MARCEL GEORGES ANTHONY | Director | Option Exercise | A | 0.77 | 25,000 | 19,250 | 25,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | BEN DOR MONY | Director | Option Exercise | A | 0.77 | 25,000 | 19,250 | 25,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Option Exercise | A | 0.77 | 25,000 | 19,250 | 25,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | A | 0.77 | 25,000 | 19,250 | 25,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | SCHLACHET DAVID | Director | Option Exercise | A | 0.77 | 25,000 | 19,250 | 25,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | Meer James | Senior VP and CFO | Option Exercise | A | 0.77 | 115,000 | 88,550 | 115,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | A | 0.77 | 135,000 | 103,950 | 135,000 | |
Feb 22 2005 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Option Exercise | A | 0.77 | 200,000 | 154,000 | 200,000 | |
Dec 02 2004 | PARS | PHARMOS CORP | AVIV HAIM | Chairman and CEO | Sell | S | 4.05 | 15,615 | 63,241 | 837,111 | 852.7 K to 837.1 K (-1.83 %) |
Dec 02 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 2.50 | 1,701 | 4,253 | 0 | |
Dec 02 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 3.95 | 1,701 | 6,719 | 260,815 | 262.5 K to 260.8 K (-0.65 %) |
Dec 02 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Buy | M | 2.50 | 1,701 | 4,253 | 262,516 | 260.8 K to 262.5 K (+0.65 %) |
Dec 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.88 | 1,250 | 2,344 | 6,250 | |
Dec 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Option Exercise | M | 1.02 | 1,250 | 1,275 | 10,250 | |
Dec 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Sell | S | 3.95 | 2,500 | 9,875 | 0 | 2.5 K to 0 (-100.00 %) |
Dec 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.88 | 1,250 | 2,344 | 2,500 | 1.3 K to 2.5 K (+100.00 %) |
Dec 02 2004 | PARS | PHARMOS CORP | GAMZU ELKAN R | Director | Buy | M | 1.02 | 1,250 | 1,275 | 1,250 | 0 to 1.3 K |
Dec 02 2004 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Option Exercise | M | 1.08 | 10,000 | 10,800 | 20,000 | |
Dec 02 2004 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Sell | S | 4.01 | 10,000 | 40,058 | 0 | 10 K to 0 (-100.00 %) |
Dec 02 2004 | PARS | PHARMOS CORP | MARSHALL LAWRENCE | Director | Buy | M | 1.08 | 10,000 | 10,800 | 10,000 | 0 to 10 K |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 1.88 | 37,500 | 70,313 | 12,500 | |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 1.02 | 23,437 | 23,906 | 70,313 | |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Option Exercise | M | 1.90 | 62,500 | 118,750 | 37,500 | |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.08 | 40,000 | 163,136 | 260,815 | 300.8 K to 260.8 K (-13.30 %) |
Dec 01 2004 | PARS | PHARMOS CORP | RIESENFELD GAD | President and COO | Sell | S | 4.02 | 33,437 | 134,517 | 300,815 | 334.3 K to 300.8 K (-10.00 %) |